LISATA THERAPEUTICS INC (LSTA)
US1280583022 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.51M | 22.59M | 32.20M | 24.60M | 16.50M | |||
| Marketable Securities | 16.35M | 27.94M | 37.10M | 70.30M | 18.10M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.84M | 3.39M | 2.70M | 1.20M | 800.00K | |||
| Total Current Assets | 37.69M | 53.92M | 71.90M | 96.20M | 35.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 278.00K | 483.00K | 800.00K | 800.00K | 600.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 210.00K | 263.00K | 300.00K | N/A | N/A | |||
| Other Non-Current Assets | 19.00K | 24.00K | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Assets | 507.00K | 770.00K | 1.10M | 800.00K | 700.00K | |||
| TOTAL ASSETS | 38.20M | 54.69M | 73.00M | 97.00M | 36.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.13M | 4.17M | 3.70M | 2.60M | 2.50M | |||
| Accounts Payable | 556.00K | 2.42M | 2.70M | 1.90M | 1.00M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 4.69M | 6.59M | 6.40M | 4.50M | 3.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 72.00K | 210.00K | 300.00K | 500.00K | 300.00K | |||
| Total Non-Current Liabilities | -182.00K | -44.00K | 100.00K | 300.00K | 0.00 | |||
| TOTAL LIABILITIES | 4.51M | 6.55M | 6.50M | 4.80M | 3.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -543.46M | -528.08M | -507.20M | -453.00M | -425.60M | |||
| Additional Paid In Capital | 577.88M | 576.97M | 574.50M | 546.00M | 458.70M | |||
| Minority Interest | -254.00K | -254.00K | -300.00K | -300.00K | -300.00K | |||
| Common Shares | 8.00K | 8.00K | 0.00 | 100.00K | 0.00 | |||
| Treasury Stock | -708.00K | -708.00K | -700.00K | -700.00K | -700.00K | |||
| Other Shareholders' Equity | -32.00K | -42.00K | 0.00 | -100.00K | 0.00 | |||
| Shares Outstanding | 8.32M | 8.15M | 7.90M | 4.00M | 1.30M | |||
| Tangible Book Value per Share | 4.02 | 5.88 | 8.39 | 23.07 | 25.00 | |||
| Total Shareholders' Equity | 33.69M | 48.15M | 66.60M | 92.30M | 32.50M | |||
| TOTAL LIABILITIES AND EQUITY | 38.20M | 54.69M | 73.00M | 97.00M | 36.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 8.03 | 8.18 | 11.23 | 21.38 | 10.09 | |||
| Return On Assets (ROA) | -54.29% | -38.10% | -74.29% | -28.32% | -22.64% | |||
| Return On Equity (ROE) | -61.56% | -43.28% | -81.43% | -29.76% | -25.08% | |||
All data in USD , ROIC based on taxRate of 0.21